EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas.

Details

Language :

English

ISSN :

15560864

Volume :

19

Issue :

10

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

180335897

Full Text :

https://doi.org/10.1016/j.jtho.2024.09.1243